Compounds > camptothecin
Page last updated: 2024-08-22

camptothecin and methylnitronitrosoguanidine

camptothecin has been researched along with methylnitronitrosoguanidine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fasullo, M; Giallanza, P; Zeng, L1
Barthelmes, HU; Boege, F; Christensen, MO; Habermeyer, M; Interthal, H; Marko, D; Mielke, C; Pouliot, JJ1
Eddy, M; Huang, RY; Kowalski, D; Vujcic, M1
Becherel, OJ; Chen, P; de Murcia, G; de Murcia, JM; Epe, B; Fusser, M; Grattan-Smith, P; Gueven, N; Haince, JF; Howe, O; Lavin, MF; McGowan, CH; Mothersill, C; Ouellet, ME; Parton, R; Poirier, GG; Waterhouse, N1
Rancourt, A; Satoh, MS1

Other Studies

5 other study(ies) available for camptothecin and methylnitronitrosoguanidine

ArticleYear
Enhanced stimulation of chromosomal translocations by radiomimetic DNA damaging agents and camptothecin in Saccharomyces cerevisiae rad9 checkpoint mutants.
    Mutation research, 2004, Mar-22, Volume: 547, Issue:1-2

    Topics: 4-Nitroquinoline-1-oxide; Camptothecin; Cell Cycle Proteins; Chromosomes, Fungal; DNA Damage; DNA, Fungal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Methylnitronitrosoguanidine; Mutagens; Mutation; Recombination, Genetic; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Translocation, Genetic

2004
TDP1 overexpression in human cells counteracts DNA damage mediated by topoisomerases I and II.
    The Journal of biological chemistry, 2004, Dec-31, Volume: 279, Issue:53

    Topics: Bacterial Proteins; Binding Sites; Blotting, Western; Camptothecin; Cell Line; Cell Line, Tumor; Cell Nucleolus; Cell Nucleus; Cell Proliferation; Cloning, Molecular; DNA; DNA Damage; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA, Ribosomal; Etoposide; Green Fluorescent Proteins; Humans; Immunoblotting; Luminescent Proteins; Methylnitronitrosoguanidine; Microscopy, Fluorescence; Mitosis; Mutation; Phosphoric Diester Hydrolases; Time Factors

2004
Genome-wide screen identifies genes whose inactivation confer resistance to cisplatin in Saccharomyces cerevisiae.
    Cancer research, 2005, Jul-01, Volume: 65, Issue:13

    Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Doxorubicin; Drug Resistance, Microbial; Fluorouracil; Gene Deletion; Gene Silencing; Genome, Fungal; Methylnitronitrosoguanidine; Open Reading Frames; Saccharomyces cerevisiae

2005
A novel form of ataxia oculomotor apraxia characterized by oxidative stress and apoptosis resistance.
    Cell death and differentiation, 2007, Volume: 14, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Apraxias; Ataxia; Blotting, Western; Camptothecin; Cells, Cultured; DNA Breaks, Single-Stranded; DNA Damage; DNA Repair; Etoposide; Female; Flow Cytometry; Humans; Hydrogen Peroxide; Male; Membrane Potential, Mitochondrial; Methylnitronitrosoguanidine; Mitomycin; Oxidative Stress; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Radiation, Ionizing; Reactive Nitrogen Species

2007
Delocalization of nucleolar poly(ADP-ribose) polymerase-1 to the nucleoplasm and its novel link to cellular sensitivity to DNA damage.
    DNA repair, 2009, Mar-01, Volume: 8, Issue:3

    Topics: Adenosine Diphosphate Ribose; Apoptosis; Apoptosis Inducing Factor; Camptothecin; Cell Nucleus; DNA Damage; DNA Repair; DNA Topoisomerases, Type I; Enzyme Inhibitors; HeLa Cells; Humans; Methylnitronitrosoguanidine; NAD; Nuclear Proteins; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Topoisomerase I Inhibitors; Transcription, Genetic

2009